Related Experiment Videos
Oxidized lipoproteins and nitric oxide
1Cell Biology Unit, Heart Research Institute, Camperdown, Sydney, New South Wales, Australia.
Current Opinion in Lipidology
|October 1, 1996
Summary
Nitric oxide (NO) normally maintains vascular tone and prevents lipoprotein oxidation. In hypercholesterolemia, oxidized lipoproteins inactivate NO, accelerating atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Biochemistry
- Pathophysiology
Background:
- Nitric oxide (NO) is crucial for vascular tone as endothelium-derived relaxing factor.
- NO also possesses anti-atherogenic properties by suppressing lipoprotein oxidation.
- In hypercholesterolemia and atherosclerosis, NO's biological activity is reduced despite normal synthesis.
Purpose of the Study:
- To investigate the mechanisms underlying nitric oxide inactivation in hypercholesterolemia.
- To understand the interplay between nitric oxide and oxidized lipoproteins in atherogenesis.
Main Methods:
- The study focuses on the biochemical interactions within arterial intima.
- Analysis of nitric oxide scavenging by oxidized lipoprotein components.
- Evaluation of indirect mechanisms involving nitric oxide scavenger release.
Main Results:
- Nitric oxide inactivation in hypercholesterolemia is mediated by oxidized lipoproteins.
- Direct reaction with NO and indirect scavenging contribute to NO depletion.
- This creates a cycle of NO deficiency and accelerated lipoprotein oxidation.
Conclusions:
- Hypercholesterolemia disrupts the balance between NO availability and lipoprotein oxidation.
- Oxidized lipoproteins promote NO depletion, contributing to atherosclerosis.
- Targeting this cycle may offer therapeutic strategies for atherosclerosis.